Lokvančić, H. 2022. HER2 positive breast cancer and its treatment with trastuzumab, where are we now?. Bioengineering Studies. 3, 2 (Dec. 2022), 35–43. DOI:https://doi.org/10.37868/bes.v3i2.id239.